Skip to main content
. 2024 Mar 13;16:e48300. doi: 10.2196/48300

Table 4.

Phenotype 5, overall ≥1 clinical diagnosis or ≥1 vitals indicated. This table depicts the full analytical results for P5 at the 80% CI.

Characteristic BRFSSa,b, n/N (%) INPCc,d, n/N (%) e (Δ80% CI)
Overall 235/934 (28.4) 151,645/548,298 (27.7) –0.7 (–3.2 to 1.7)f
Gender

Men 127/410 (31) 63,992/212,684 (30.1) –0.9 (–11.9 to 10.1)

Women 137/524 (26.1) 87,652/335,548 (26.1) 0 (–8 to 8.1)f
Race

Black or African American 54/152 (35.7) 71,464/148,120 (48.2) 12.5 (6.4 to 18.7)

White 187/702 (26.6) 137,674/308,224 (44.7) 18.1 (15.4 to 20.8)

Other 18/80 (22.6) 31,158/91,954 (33.9) 11.3 (4.6 to 17.9)
Age group (y)

18-39 21/197 (10.8) 36,157/214,685 (16.8) 6 (3 to 9.1)f

40-64 133/406 (32.8) 74,864/240,084 (31.2) –1.6 (–5.3 to 2.1)f

65+ 204/331 (61.6) 38,356/88,569 (43.3) –18.3 (–22 to –14.6)
Men by race

Black or African American 24/60 (40.6) 21,091/56,004 (37.7) –2.9 (–9.1 to 3.2)f

White 91/314 (29.1) 37,622/120,672 (31.2) 2.1 (–2 to 6.2)f

Other 9/36 (24.1) 5,268/36,008 (14.6) –9.5 (–19.3 to 0.4)
Women by race

Black or African American 30/92 (32.2) 30,285/88,868 (34.1) 1.9 (–5.1 to 1.6)f

White 95/388 (24.4) 41,094/181,412 (22.7) –1.7 (–6.1 to 9.8)f

Other 9/44 (20.8) 5,959/54,954 (10.8) –10 (–18.7 to –1.3)
Men by age group (y)

18-39 18/99 (18.5) 14,819/77,992 (19) 0.5 (–5 to 6)f

40-64 56/178 (31.2) 33,567/98,778 (34) 2.8 (–2.6 to 8.2)f

65+ 90/133 (67.4) 15,011/34,606 (43.4) –24 (–29.8 to –18.3)
Women by age group (y)

18-39 3/98 (3.4) 21,331/136,663 (15.6) 12.2 (9.9 to 14.5)

40-64 78/228 (34.2) 41,296/141,286 (29.2) –5 (–10.2 to 0.3)

65+ 114/198 (57.5) 23,345/53,954 (43.3) –14.2 (–21.5 to –6.9)

aBRFSS: Behavioral Risk Factor Surveillance System.

bSample size=934.

cIndiana Network for Patient Care.

dSample size=548,298.

eΔ: mean difference.

fBehavioral Risk Factor Surveillance System and Indiana Network for Patient Care phenotypes were determined as statistically equivalent by the two 1-sided t test method.